Word

APOLLO THERAPEUTICS

Status

Registered

Status Code

700

Status Date

Tuesday, September 26, 2023

Serial Number

90798637

Registration Number

7172183

Registration Date

Tuesday, September 26, 2023

Mark Type

4000

Filing Date

Monday, June 28, 2021

Published for Opposition

Tuesday, April 11, 2023

Trademark Owner History

Apollo Therapeutics LLP - Original Registrant

Classifications

41 Education services, namely, providing instruction in the field of pharmaceutical and therapeutic medical education; arranging and conducting of conferences, congresses, courses, in particular in the fields of medicine and pharmaceuticals; publishing services, namely, the publication of periodicals, books, magazines, and articles in the field of medicine, pharmaceuticals, and therapeutics; publication of periodicals, books, magazines, articles, in particular in the fields of medicine, pharmaceuticals and therapeutics

5 Therapeutic pharmaceuticals for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy in the nature of cells for medical use, namely autologous gene-engineered cells; medical preparations for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases

36 Financial sponsorship in the form of providing financial resources to non-hospital partnerships, associations and companies, to aid in the research, development, production, import, export, retail, wholesale, promotion, commercial distribution and commercialisation of pharmaceutical, therapeutic and medicinal products and preparations

35 Collection of data and management of data for business purposes in connection with clinical research, testing, trial and development of pharmaceuticals, therapeutics and medical devices; computerized database management and data processing services in the field of medical, pharmaceutical and therapeutic treatment

44 Non-emergency and non-clinical medical and pharmaceutical consulting services related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines; non-emergency medical analysis services for diagnostic and treatment purposes related to the use of pharmaceutical preparations, namely biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines, provided by medical laboratories; medical analysis and examination services related to the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases, provided by medical laboratories; medical treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; advisory services relating to medical and pharmaceutical science, namely, medical advisory services and pharmaceutical advisory services in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases

42 Scientific, medical and pharmaceutical research and development services; clinical research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; pharmaceutical drug development services; scientific investigations for medical purposes; medical laboratory services; laboratory research services related to pharmaceuticals; advisory services relating to medical and pharmaceutical science research in the field of the use of biologics, biosimilars, small molecules, gene-engineered cell therapy and vaccines for the treatment of cardiovascular diseases, blood disorders, respiratory diseases, asthma, central nervous system disorders, cancer and tumors, diseases and disorders of the autoimmune system, allergies, renal transplant, hypertension, chronic kidney disease, and metabolic diseases; research and development of pharmaceutical preparations

"THERAPEUTICS"

Trademark Events

Sep 26, 2023

Notice Of Registration Confirmation Emailed

Sep 26, 2023

Registered-Principal Register

Aug 21, 2023

1(B) Basis Deleted; Proceed To Registration

Jul 10, 2023

Notice Of Allowance Cancelled

Aug 21, 2023

Case Assigned To Intent To Use Paralegal

Jul 10, 2023

Teas Delete 1(B) Basis Received

Jun 6, 2023

Noa E-Mailed - Sou Required From Applicant

Apr 11, 2023

Official Gazette Publication Confirmation E-Mailed

Apr 11, 2023

Published For Opposition

Mar 22, 2023

Notification Of Notice Of Publication E-Mailed

Mar 3, 2023

Approved For Pub - Principal Register

Mar 1, 2023

Examiner's Amendment Entered

Mar 1, 2023

Notification Of Examiners Amendment E-Mailed

Mar 1, 2023

Examiners Amendment E-Mailed

Mar 1, 2023

Examiners Amendment -Written

Feb 21, 2023

Teas/Email Correspondence Entered

Feb 21, 2023

Correspondence Received In Law Office

Feb 21, 2023

Teas Response To Office Action Received

Jan 6, 2023

Notification Of Non-Final Action E-Mailed

Jan 6, 2023

Non-Final Action E-Mailed

Jan 6, 2023

Non-Final Action Written

Nov 10, 2022

Teas/Email Correspondence Entered

Nov 9, 2022

Correspondence Received In Law Office

Nov 9, 2022

Teas Response To Office Action Received

Aug 30, 2022

Assigned To Examiner

Jun 7, 2022

Teas Change Of Correspondence Received

Jun 7, 2022

Teas Withdrawal Of Attorney Received-Firm Retains

Jun 7, 2022

Attorney/Dom.Rep.Revoked And/Or Appointed

Jun 7, 2022

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jun 2, 2022

Notification Of Non-Final Action E-Mailed

Jun 2, 2022

Non-Final Action E-Mailed

Jun 2, 2022

Non-Final Action Written

Mar 18, 2022

Assigned To Examiner

Sep 10, 2021

New Application Office Supplied Data Entered

Aug 6, 2021

Teas Change Of Correspondence Received

Aug 6, 2021

Attorney/Dom.Rep.Revoked And/Or Appointed

Aug 6, 2021

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jul 1, 2021

New Application Entered